Skip to main content

Advertisement

SpringerLink
Log in

Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hochleitner BW, Bosmuller C, Nehoda H, Fruhwirt M, Simma B, Ellemunter H et al. Increased tacrolimus levels during diarrhea. Transpl Int 2001; 14: 230–233.

    Article  CAS  Google Scholar 

  2. Harper J, Smith C, Rubins A, Green A, Jackson K, Zigure S et al. A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis. J Invest Dermatol 2005; 124: 695–699.

    Article  CAS  Google Scholar 

  3. Food and Drug Administration. Protopic® (tacrolimus) Ointment 0.03% Ointment 0.1% Monography. http://www.fda.gov/cder/foi/label/2006/050777s012lbl.pdf.

  4. Simpson D, Noble S . Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions. Drugs 2005; 65: 827–858.

    Article  CAS  Google Scholar 

  5. Allen A, Siegfried E, Silverman R, Williams ML, Elias PM, Szabo SK et al. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 2001; 137: 747–750.

    CAS  PubMed  Google Scholar 

  6. Allen DM, Esterly NB . Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. Arch Dermatol 2002; 138: 1259–1260.

    Article  Google Scholar 

  7. Russell RK, Richardson N, Wilson DC . Systemic absorption with complications during topical tacrolimus treatment for orofacial Crohn disease. J Pediatr Gastroenterol Nutr 2001; 32: 207–208.

    Article  CAS  Google Scholar 

  8. Shah KN, Yan AC . Low but detectable serum levels of tacrolimus seen with the use of very dilute, extemporaneously compounded formulations of tacrolimus ointment in the treatment of patients with Netherton syndrome. Arch Dermatol 2006; 142: 1362–1363.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacy Department, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada

    S Prot-Labarthe & R Therrien

  2. Division of Hematology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada

    M A Champagne, M Duval & C Joubert

Authors
  1. S Prot-Labarthe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Therrien
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M A Champagne
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Duval
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C Joubert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R Therrien.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prot-Labarthe, S., Therrien, R., Champagne, M. et al. Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease. Bone Marrow Transplant 40, 295–296 (2007). https://doi.org/10.1038/sj.bmt.1705726

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705726

  • Springer Nature Limited

This article is cited by

Search

Navigation